Stemline Therapeutics - 48 Year Dividend Yield History | STML
Historical dividend payout and yield for Stemline Therapeutics (STML) since 1971. The current TTM dividend payout for Stemline Therapeutics (STML) as of February 20, 2019 is $0.00. The current dividend yield for Stemline Therapeutics as of February 20, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Stemline Therapeutics, Inc. is a biopharmaceutical company developing oncology therapeutics that target cancer stem cells and tumor bulk. The company is developing SL-401, a biologic-drug conjugate, for relapsed or refractory acute myeloid leukemia; and SL-701, a synthetic peptide vaccine, for pediatric and adult high-grade gliomas. Stemline Therapeutics, Inc. is based in New York.